{"id":11222,"title":"TheBizLounge: Oxford Biodynamics’ half year, plus billionaire neighbours from hell!","publisher":"Share Talk","author":"sharetalk","published":"2017-06-13T13:14:15+00:00","modified":"2017-06-13T14:08:35+00:00","canonical_url":"https://www.share-talk.com/thebizlounge-oxford-biodynamics-half-year-plus-billionaire-neighbours-from-hell/","markdown_url":"https://www.share-talk.com/thebizlounge-oxford-biodynamics-half-year-plus-billionaire-neighbours-from-hell.md","json_url":"https://www.share-talk.com/thebizlounge-oxford-biodynamics-half-year-plus-billionaire-neighbours-from-hell.json","category":"TheBizLounge","categories":["TheBizLounge"],"tags":["Foxtons","Jon Hunt","OBD","Oxford Biodynamics"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1","format":"news","language":"en-GB","content":"![](https://www.share-talk.com/wp-content/uploads/2017/06/MJ-Biz-Lounge-13-Jun-1024x575.jpg)\n\nTaking the stress out of stocks…\n\nNew AIM listed biotech firm Oxford Biodynamics reported first set of results as listed company today. After the period end, though it signed up two top global pharmas, and inked licence deals in Asia, so could it be an early stock to buy? Plus even billionaires can find it tough going with the neighbours…"}